INS and cancer: As the inflammatory response is known to interfere with insulin signaling, chronic inflammation is regarded as a causal factor for the progression of various metabolic disorders, such as obesity, insulin resistance, hyperlipidemia, hyperglycemia, type 2 diabetes, certain types of cancer, and atherosclerosis [43,45].